US Stock MarketDetailed Quotes

JNJ Johnson & Johnson

Watchlist
  • 160.620
  • +0.400+0.25%
Close Aug 9 16:00 ET
  • 160.650
  • +0.030+0.02%
Pre 06:03 ET
386.65BMarket Cap10.67P/E (TTM)

Johnson & Johnson Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Oct 1, 2023
(Q2)Jun 30, 2023
(Q1)Apr 2, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Oct 2, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.70%5.63B
12.28%3.66B
7.54%22.79B
46.97%7.86B
19.18%7.49B
-25.07%4.18B
-18.15%3.26B
-9.47%21.19B
-6.66%5.35B
6.28B
Net income from continuing operations
-8.90%4.69B
4,886.76%3.26B
95.94%35.15B
15.03%4.05B
483.85%26.03B
6.86%5.14B
-101.32%-68M
-14.07%17.94B
-25.68%3.52B
--4.46B
Operating gains losses
----
----
-5,452.89%-21.1B
--0
---21.05B
13.33%-39M
95.24%-8M
38.41%-380M
-943.75%-167M
--0
Depreciation and amortization
-7.86%1.78B
-3.46%1.82B
7.40%7.49B
4.01%1.84B
8.55%1.83B
10.89%1.93B
6.27%1.88B
-5.68%6.97B
-3.85%1.77B
--1.69B
Deferred tax
13.02%-695M
-1.23%-1.56B
-152.19%-4.19B
-392.36%-2.41B
502.88%560M
43.85%-799M
-66.63%-1.54B
20.01%-1.66B
70.10%825M
---139M
Other non cash items
----
----
--483M
----
----
----
----
----
----
----
Change In working capital
81.17%-452M
-114.94%-338M
162.50%2.51B
362.07%3.25B
-1,906.67%-602M
-79,933.33%-2.4B
182.62%2.26B
5.36%-4.01B
20.98%-1.24B
---30M
-Change in receivables
-62.20%-884M
-416.67%-279M
51.63%-624M
-24.58%227M
-22.93%-252M
43.17%-545M
87.35%-54M
46.29%-1.29B
151.54%301M
---205M
-Change in inventory
-80.18%-391M
33.59%-348M
47.65%-1.32B
119.08%124M
-13.87%-706M
66.97%-217M
12.67%-524M
-102.48%-2.53B
-828.57%-650M
---620M
-Change in payables and accrued expense
94.04%2.93B
3.46%-2.48B
113.66%2.35B
75.76%1.68B
31.58%1.73B
-8.26%1.51B
8.70%-2.57B
-54.94%1.1B
-57.56%957M
--1.31B
-Change in other current assets
332.31%532M
449.62%3.2B
-606.55%-3.48B
45.46%-2.11B
-121.43%-222M
-109.04%-229M
-191.96%-915M
134.98%687M
4.20%-3.88B
--1.04B
-Change in other current liabilities
9.59%-2.64B
-106.75%-427M
382.36%5.59B
64.02%3.33B
26.10%-1.15B
-13.83%-2.92B
5,652.73%6.33B
-86.52%-1.98B
131.36%2.03B
---1.55B
Cash from discontinued investing activities
Operating cash flow
34.70%5.63B
12.28%3.66B
7.54%22.79B
46.97%7.86B
19.18%7.49B
-25.07%4.18B
-18.15%3.26B
-9.47%21.19B
-6.66%5.35B
--6.28B
Investing cash flow
Cash flow from continuing investing activities
-262.47%-13.69B
-114.00%-464M
107.10%878M
72.66%-1.2B
249.38%2.54B
-43.08%-3.78B
191.22%3.32B
-42.47%-12.37B
17.97%-4.4B
-1.7B
Net PPE purchase and sale
13.17%-976M
6.49%-807M
-13.32%-4.54B
-0.13%-1.59B
-1.58%-967M
-30.24%-1.12B
-42.17%-863M
-9.78%-4.01B
-12.16%-1.59B
---952M
Net intangibles purchase and sale
----
----
---470M
----
----
----
----
--0
----
----
Net business purchase and sale
---13B
---1.81B
--0
--0
--0
--0
--0
-29,320.00%-17.65B
-28,450.00%-17.13B
--1M
Net investment purchase and sale
161.63%1.6B
-91.26%349M
-8.03%8.48B
-80.96%2.68B
1,163.86%4.42B
-52.19%-2.6B
247.03%3.99B
271.21%9.23B
519.32%14.06B
---415M
Net other investing changes
-2,484.31%-1.32B
870.43%1.81B
-4,089.23%-2.59B
-811.33%-1.82B
-170.75%-907M
-125.00%-51M
410.00%186M
-84.41%65M
148.21%256M
---335M
Cash from discontinued investing activities
Investing cash flow
-262.47%-13.69B
-114.00%-464M
107.10%878M
72.66%-1.2B
249.38%2.54B
-43.08%-3.78B
191.22%3.32B
-42.47%-12.37B
17.97%-4.4B
---1.7B
Financing cash flow
Cash flow from continuing financing activities
225.92%7.54B
-91.10%546M
-78.39%-15.83B
-373.82%-4.66B
-188.33%-11.32B
-164.97%-5.99B
239.98%6.14B
36.85%-8.87B
149.48%1.7B
-3.93B
Net issuance payments of debt
262.65%11.54B
-66.04%4.37B
-136.69%-2.73B
-115.03%-1.1B
-6,336.13%-7.42B
-78,955.56%-7.1B
41,448.39%12.88B
852.73%7.45B
243,200.00%7.29B
--119M
Net common stock issuance
-103.52%-136M
58.30%-1.48B
86.53%-813M
83.64%-216M
57.51%-920M
496.71%3.86B
-124.29%-3.54B
-74.62%-6.04B
-32.53%-1.32B
---2.17B
Cash dividends paid
3.46%-2.99B
2.48%-2.87B
-0.75%-11.77B
3.01%-2.87B
3.33%-2.87B
-4.07%-3.09B
-5.56%-2.94B
-5.89%-11.68B
-5.84%-2.95B
---2.97B
Proceeds from stock option exercised by employees
-64.15%95M
1,872.73%195M
-17.68%1.09B
-55.69%187M
650.57%653M
-46.89%265M
-103.43%-11M
28.28%1.33B
85.09%422M
--87M
Net other financing activities
-1,432.88%-973M
227.38%321M
-2,564.62%-1.6B
61.80%-665M
-175.50%-758M
-93.79%73M
32.44%-252M
-83.54%65M
-1,481.75%-1.74B
--1B
Cash from discontinued financing activities
Financing cash flow
225.92%7.54B
-91.10%546M
-78.39%-15.83B
-373.82%-4.66B
-188.33%-11.32B
-164.97%-5.99B
239.98%6.14B
36.85%-8.87B
149.48%1.7B
---3.93B
Net cash flow
Beginning cash position
-5.18%25.47B
54.73%21.86B
-2.48%14.13B
73.74%19.73B
92.87%21.18B
156.76%26.87B
-2.48%14.13B
3.59%14.49B
-35.50%11.36B
--10.98B
Current changes in cash
90.87%-510M
-70.58%3.74B
16,441.67%7.84B
-24.39%2.01B
-295.59%-1.29B
-920.12%-5.59B
414.60%12.71B
-107.06%-48M
186.59%2.65B
--658M
Effect of exchange rate changes
12.37%-85M
-546.43%-125M
64.10%-112M
5.04%125M
41.26%-168M
39.75%-97M
75.00%28M
-75.28%-312M
324.53%119M
---286M
End cash Position
17.44%24.88B
-5.18%25.47B
54.73%21.86B
54.73%21.86B
73.74%19.73B
92.87%21.18B
156.76%26.87B
-2.48%14.13B
-2.48%14.13B
--11.36B
Free cash flow
52.29%4.66B
19.05%2.85B
3.45%17.78B
54.24%5.8B
22.32%6.52B
-35.18%3.06B
-29.00%2.39B
-13.02%17.19B
-12.83%3.76B
--5.33B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Oct 1, 2023(Q2)Jun 30, 2023(Q1)Apr 2, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Oct 2, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.70%5.63B12.28%3.66B7.54%22.79B46.97%7.86B19.18%7.49B-25.07%4.18B-18.15%3.26B-9.47%21.19B-6.66%5.35B6.28B
Net income from continuing operations -8.90%4.69B4,886.76%3.26B95.94%35.15B15.03%4.05B483.85%26.03B6.86%5.14B-101.32%-68M-14.07%17.94B-25.68%3.52B--4.46B
Operating gains losses ---------5,452.89%-21.1B--0---21.05B13.33%-39M95.24%-8M38.41%-380M-943.75%-167M--0
Depreciation and amortization -7.86%1.78B-3.46%1.82B7.40%7.49B4.01%1.84B8.55%1.83B10.89%1.93B6.27%1.88B-5.68%6.97B-3.85%1.77B--1.69B
Deferred tax 13.02%-695M-1.23%-1.56B-152.19%-4.19B-392.36%-2.41B502.88%560M43.85%-799M-66.63%-1.54B20.01%-1.66B70.10%825M---139M
Other non cash items ----------483M----------------------------
Change In working capital 81.17%-452M-114.94%-338M162.50%2.51B362.07%3.25B-1,906.67%-602M-79,933.33%-2.4B182.62%2.26B5.36%-4.01B20.98%-1.24B---30M
-Change in receivables -62.20%-884M-416.67%-279M51.63%-624M-24.58%227M-22.93%-252M43.17%-545M87.35%-54M46.29%-1.29B151.54%301M---205M
-Change in inventory -80.18%-391M33.59%-348M47.65%-1.32B119.08%124M-13.87%-706M66.97%-217M12.67%-524M-102.48%-2.53B-828.57%-650M---620M
-Change in payables and accrued expense 94.04%2.93B3.46%-2.48B113.66%2.35B75.76%1.68B31.58%1.73B-8.26%1.51B8.70%-2.57B-54.94%1.1B-57.56%957M--1.31B
-Change in other current assets 332.31%532M449.62%3.2B-606.55%-3.48B45.46%-2.11B-121.43%-222M-109.04%-229M-191.96%-915M134.98%687M4.20%-3.88B--1.04B
-Change in other current liabilities 9.59%-2.64B-106.75%-427M382.36%5.59B64.02%3.33B26.10%-1.15B-13.83%-2.92B5,652.73%6.33B-86.52%-1.98B131.36%2.03B---1.55B
Cash from discontinued investing activities
Operating cash flow 34.70%5.63B12.28%3.66B7.54%22.79B46.97%7.86B19.18%7.49B-25.07%4.18B-18.15%3.26B-9.47%21.19B-6.66%5.35B--6.28B
Investing cash flow
Cash flow from continuing investing activities -262.47%-13.69B-114.00%-464M107.10%878M72.66%-1.2B249.38%2.54B-43.08%-3.78B191.22%3.32B-42.47%-12.37B17.97%-4.4B-1.7B
Net PPE purchase and sale 13.17%-976M6.49%-807M-13.32%-4.54B-0.13%-1.59B-1.58%-967M-30.24%-1.12B-42.17%-863M-9.78%-4.01B-12.16%-1.59B---952M
Net intangibles purchase and sale -----------470M------------------0--------
Net business purchase and sale ---13B---1.81B--0--0--0--0--0-29,320.00%-17.65B-28,450.00%-17.13B--1M
Net investment purchase and sale 161.63%1.6B-91.26%349M-8.03%8.48B-80.96%2.68B1,163.86%4.42B-52.19%-2.6B247.03%3.99B271.21%9.23B519.32%14.06B---415M
Net other investing changes -2,484.31%-1.32B870.43%1.81B-4,089.23%-2.59B-811.33%-1.82B-170.75%-907M-125.00%-51M410.00%186M-84.41%65M148.21%256M---335M
Cash from discontinued investing activities
Investing cash flow -262.47%-13.69B-114.00%-464M107.10%878M72.66%-1.2B249.38%2.54B-43.08%-3.78B191.22%3.32B-42.47%-12.37B17.97%-4.4B---1.7B
Financing cash flow
Cash flow from continuing financing activities 225.92%7.54B-91.10%546M-78.39%-15.83B-373.82%-4.66B-188.33%-11.32B-164.97%-5.99B239.98%6.14B36.85%-8.87B149.48%1.7B-3.93B
Net issuance payments of debt 262.65%11.54B-66.04%4.37B-136.69%-2.73B-115.03%-1.1B-6,336.13%-7.42B-78,955.56%-7.1B41,448.39%12.88B852.73%7.45B243,200.00%7.29B--119M
Net common stock issuance -103.52%-136M58.30%-1.48B86.53%-813M83.64%-216M57.51%-920M496.71%3.86B-124.29%-3.54B-74.62%-6.04B-32.53%-1.32B---2.17B
Cash dividends paid 3.46%-2.99B2.48%-2.87B-0.75%-11.77B3.01%-2.87B3.33%-2.87B-4.07%-3.09B-5.56%-2.94B-5.89%-11.68B-5.84%-2.95B---2.97B
Proceeds from stock option exercised by employees -64.15%95M1,872.73%195M-17.68%1.09B-55.69%187M650.57%653M-46.89%265M-103.43%-11M28.28%1.33B85.09%422M--87M
Net other financing activities -1,432.88%-973M227.38%321M-2,564.62%-1.6B61.80%-665M-175.50%-758M-93.79%73M32.44%-252M-83.54%65M-1,481.75%-1.74B--1B
Cash from discontinued financing activities
Financing cash flow 225.92%7.54B-91.10%546M-78.39%-15.83B-373.82%-4.66B-188.33%-11.32B-164.97%-5.99B239.98%6.14B36.85%-8.87B149.48%1.7B---3.93B
Net cash flow
Beginning cash position -5.18%25.47B54.73%21.86B-2.48%14.13B73.74%19.73B92.87%21.18B156.76%26.87B-2.48%14.13B3.59%14.49B-35.50%11.36B--10.98B
Current changes in cash 90.87%-510M-70.58%3.74B16,441.67%7.84B-24.39%2.01B-295.59%-1.29B-920.12%-5.59B414.60%12.71B-107.06%-48M186.59%2.65B--658M
Effect of exchange rate changes 12.37%-85M-546.43%-125M64.10%-112M5.04%125M41.26%-168M39.75%-97M75.00%28M-75.28%-312M324.53%119M---286M
End cash Position 17.44%24.88B-5.18%25.47B54.73%21.86B54.73%21.86B73.74%19.73B92.87%21.18B156.76%26.87B-2.48%14.13B-2.48%14.13B--11.36B
Free cash flow 52.29%4.66B19.05%2.85B3.45%17.78B54.24%5.8B22.32%6.52B-35.18%3.06B-29.00%2.39B-13.02%17.19B-12.83%3.76B--5.33B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday-0.15%